Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.
Also called NCT06552637
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 270 participants
- Registry
-
NCT06552637
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Georgia
- Registry status
- Recruiting
Technical summary
Registry record NCT06552637. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-08 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Acronym
- RECOVER-HF
- Intervention (Device)
- Synchronized Diaphragmatic Stimulation
- Lead sponsor
- VisCardia Inc.
- Collaborator
- Clinical Accelerator
- Collaborator
- Duke Clinical Research Institute
Record details
- Record id
cardio:ct-nct06552637- Content hash
966207b380196d5abd9e8ee8dad9625ec7b97f429a7c4138b7e6d348a75bd42d